SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News
Covagen
Covagen
Company

Last deal

$66.13M
Local Amount - CHF 58.9M

Amount

Series B

Stage

09.12.2013

Date

3

all rounds

$106.63M

Total amount

date founded

Financing round

General

About Company
Covagen is a biopharmaceutical company that develops protein-based therapeutics for the treatment of inflammatory diseases and cancer..

Industry

Sector :

Subsector :

founded date

01.01.2007

founders

Number of employees

11-50

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Their lead FynomAb COVA322 is being developed for the treatment of inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis. Covagen's proprietary platform allows them to create FynomAbs with tailored architectures to maximize efficacy, and they have a strategic research collaboration and license agreement with Mitsubishi Tanabe / TRL for the development of bispecific FynomAbs against target pairs selected by Mitsubishi Tanabe / TRL. Covagen was founded in 2007 as a spin-off company from ETH Zurich and is supported by a strong syndicate of investors including Novartis Venture Fund, Edmond de Rothschild Investment Partners, Gimv, Seroba Kernel Life Sciences, Ventech, Ascent Biomedical Venture Management, MP Healthcare Venture Management, and Baxter Ventures.
Contacts

location

8952 Schlieren, Switzerland

Phone number

Website URL

http://www.covagen.com

Social url

Similar Companies
1000
AltruBio
AltruBioAltruBio is a biopharmaceutical company developing targeted antibody therapeutics for cancer and immune-related inflammatory diseases.
AltruBio

AltruBio

AltruBio is a biopharmaceutical company developing targeted antibody therapeutics for cancer and immune-related inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Los Altos, CA, USA

total rounds

5

total raised

$327.61M
Sagimet Biosciences
Sagimet BiosciencesSagimet Biosciences develops novel therapeutics to treat metabolic diseases and specific cancers.
Sagimet Biosciences

Sagimet Biosciences

Sagimet Biosciences develops novel therapeutics to treat metabolic diseases and specific cancers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

San Mateo, CA, USA

total rounds

13

total raised

$406.16M
Arvinas
ArvinasArvinas is a pharmaceutical company that develops novel therapeutics to treat a variety of diseases.
Arvinas

Arvinas

Arvinas is a pharmaceutical company that develops novel therapeutics to treat a variety of diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

New Haven, CT, USA

total rounds

4

total raised

$461.6M

count Of Investments

1
Apogenix
ApogenixApogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Apogenix

Apogenix

Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Heidelberg, Germany

total rounds

3

total raised

$56.31M
M&A Details
1

Transaction name

Acquired by Cilag

Acquired by

Cilag
Cilag

Cilag

announced date

25.08.2014

Financials

Funding Rounds
4
3

Number of Funding Rounds

$106.63M

Money Raised

Their latest funding was raised on 09.12.2013. Their latest investor MP Healthcare Venture Management. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
09.12.2013
Series B
9
$66.13M
Local Amount - CHF 58.9M
Gimv
Gimv
29.11.2010
Series A
3
$6.3M
—
01.12.2009
Series A
1
$34.2M
Ventech
Ventech
Gimv

Gimv

Gimv identifies and supports innovative companies with high-growth potential to become market leaders.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Antwerp, Belgium

count Of Investments

154

count Of Exists

49
Ventech

Ventech

Ventech is a European & Chinese early-stage investment fund that invests in the digital economy.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Paris, France

count Of Investments

197

count Of Exists

41
Co-Investors
Investors
9
2

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
MP Healthcare Venture Management
MP Healthcare Venture Management
No
Series B
—
Andera Partners
Andera Partners
No
Series B
—
Baxter Ventures
Baxter Ventures
No
Series B
—
MP Healthcare Venture Management

MP Healthcare Venture Management

MP Healthcare Venture Management is a venture capital firm that invests in innovative research-driven companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Boston, MA, USA

count Of Investments

33

count Of Exists

7
Andera Partners

Andera Partners

Andera Partners is a venture capital firm that invests in various sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Paris, France

total rounds

1

total raised

$48.5M

count Of Investments

168

count Of Exists

39
Baxter Ventures

Baxter Ventures

Baxter Ventures invests in innovative healthcare companies to improve patient care and maximize value for investors and entrepreneurs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Venture Capital

Location

Deerfield, IL, USA

count Of Investments

15

count Of Exists

3

People

Founders
1
Julian Bertschinger
Julian Bertschinger

Julian Bertschinger

Julian Bertschinger is a Global Head External Innovation DPDS, Janssen R&D at Johnson & Johnson. He Attended Eidgenössische Technische Hochschule Zürich.

current job

Johnson & Johnson
Johnson & Johnson

organization founded

1
Julian Bertschinger

Julian Bertschinger

Employee Profiles
4
Dragan Grabulovski
Dragan Grabulovski

Dragan Grabulovski

Co-Founder & CSO

Co-Founder & CSO

Raymond Hill
Raymond Hill

Raymond Hill

Non-Executive Director

Non-Executive Director

Activity

Recent News
0